| |
| |
|
| Insider
Information: |
Ferreira Juan Camilo Arjona |
| Relationship: |
Officer |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
13 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$280 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13 |
|
|
| Total
Value |
$280 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
16
|
|
Stock
price went up :
|
0
|
11
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.2
|
| Percentage
Gain/Loss : |
0.0%
|
 632.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myovant Sciences Ltd. |
MYOV |
Chief Medical Officer |
2023-03-10 |
0 |
2017-08-15 |
0 |
Premium* |
|
|
Organon & Co. |
OGN |
Officer |
2024-01-01 |
13 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OGN |
Organon & Co. |
Head of R&D & CMOOfficer |
• – – |
2024-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13 |
|
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2017-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2019-02-15 |
4 |
S |
$21.15 |
$5,499 |
D/D |
(260) |
9,740 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2019-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
47,570 |
57,310 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
87,805 |
145,115 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-06-23 |
4 |
OE |
$7.78 |
$31,540 |
D/D |
4,054 |
149,169 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-06-23 |
4 |
AS |
$20.00 |
$81,080 |
D/D |
(4,054) |
145,115 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-06-24 |
4 |
OE |
$7.78 |
$135,730 |
D/D |
17,446 |
162,561 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-06-24 |
4 |
AS |
$20.00 |
$348,920 |
D/D |
(17,446) |
145,115 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-08-19 |
4 |
AS |
$20.00 |
$12,700 |
D/D |
(635) |
145,115 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-08-19 |
4 |
OE |
$7.78 |
$4,940 |
D/D |
635 |
145,750 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-08-27 |
4 |
AS |
$18.80 |
$133,273 |
D/D |
(7,089) |
138,026 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-08-28 |
4 |
OE |
$7.78 |
$16,011 |
D/D |
2,058 |
140,084 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-08-28 |
4 |
AS |
$20.01 |
$41,181 |
D/D |
(2,058) |
138,026 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-08-31 |
4 |
OE |
$7.78 |
$87,968 |
D/D |
11,307 |
149,333 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-08-31 |
4 |
AS |
$20.01 |
$226,197 |
D/D |
(11,307) |
138,026 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-09-15 |
4 |
AS |
$21.76 |
$152,389 |
D/D |
(7,000) |
138,026 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-09-15 |
4 |
OE |
$7.78 |
$54,460 |
D/D |
7,000 |
145,026 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-11-13 |
4 |
OE |
$7.78 |
$54,460 |
D/D |
7,000 |
145,026 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-11-13 |
4 |
AS |
$20.00 |
$140,000 |
D/D |
(7,000) |
138,026 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-11-17 |
4 |
OE |
$7.78 |
$54,460 |
D/D |
7,000 |
145,026 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-11-17 |
4 |
AS |
$20.00 |
$140,000 |
D/D |
(7,000) |
138,026 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-11-30 |
4 |
S |
$23.65 |
$46,780 |
D/D |
(1,978) |
136,048 |
0 |
% |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-12-10 |
4 |
OE |
$7.78 |
$77,800 |
D/D |
10,000 |
146,048 |
0 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
Chief Medical Officer |
• – – |
2020-12-10 |
4 |
AS |
$26.04 |
$260,362 |
D/D |
(10,000) |
136,048 |
0 |
% |
|
62 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
